X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/sparx-biopharmaceutical-announces-fda-greenlight-for-ind-application-of-spx-303-a-first-in-human-anti-lilrb2pd-l1-antibody-drug-301971522.html